Evidence map›Paper›PMID 39050540›Full record

ReviewFrontiers in medicine2024

A comprehensive analysis of digital health-focused Living Labs: innovative approaches to dementia.

Teodora Figueiredo, Luís Midão, Joana Carrilho, Diogo Videira Henriques, Sara Alves, Natália Duarte, Maria João Bessa, José María Fidalgo, Maria García, David Facal and 5 more

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Teodora FigueiredoCINTESIS@RISE, Biochemistry Lab of the Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Luís MidãoCINTESIS@RISE, Biochemistry Lab of the Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Joana CarrilhoCINTESIS@RISE, Biochemistry Lab of the Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Diogo Videira HenriquesCINTESIS@RISE, Biochemistry Lab of the Faculty of Pharmacy of the University of Porto, Porto, Portugal.
Sara AlvesSanta Casa da Misericórdia de Riba D'Ave/CIDIFAD - Centro de Investigação, Diagnóstico, Formação e Acompanhamento das Demências, Braga, Portugal.
Natália DuarteSanta Casa da Misericórdia de Riba D'Ave/CIDIFAD - Centro de Investigação, Diagnóstico, Formação e Acompanhamento das Demências, Braga, Portugal.
Maria João BessaUPTEC-Science and Technology Park of University of Porto, Porto, Portugal.
José María FidalgoACIS-Agencia Gallega para la Gestión del Conocimiento en Salud, Santiago de Compostela, Spain.
Maria GarcíaACIS-Agencia Gallega para la Gestión del Conocimiento en Salud, Santiago de Compostela, Spain.
David FacalDepartment of Developmental Psychology, IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Alba FelpeteDepartment of Developmental Psychology, IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Iván Rarís FilgueiraAFAGA Alzheimer - Asociación de Familiares de Enfermos de Alzheimer y otras Demencias de Galicia, Vigo, Spain.
Juan Carlos BernárdezAFAGA Alzheimer - Asociación de Familiares de Enfermos de Alzheimer y otras Demencias de Galicia, Vigo, Spain.
Maxi RodríguezAFAGA Alzheimer - Asociación de Familiares de Enfermos de Alzheimer y otras Demencias de Galicia, Vigo, Spain.
Elísio CostaCINTESIS@RISE, Biochemistry Lab of the Faculty of Pharmacy of the University of Porto, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of dementia demands innovative solutions; however, existing technological products often lack tailored support for individuals living with this condition. The Living Lab approach, as a collaborative innovation method, holds promise in addressing this issue by actively involving end-users in the design and development of solutions adapted to their needs. Despite this potential, the approach still faces challenges due to its lack of recognition as a research methodology and its absence of tailored guidelines, particularly in dementia care, prompting inquiries into its effectiveness. This narrative review aims to fill this gap by identifying and analysing digital health Living Labs focusing on dementia solutions. Additionally, it proposes guidelines for enhancing their operations, ensuring sustainability, scalability, and greater impact on dementia care. Fifteen Living Labs were identified and analyzed. Based on trends, best practices, and literature, the guidelines emphasize user engagement, interdisciplinary collaboration, technological infrastructure, regulatory compliance, transparent innovation processes, impact measurement, sustainability, scalability, dissemination, and financial management. Implementing these guidelines can enhance the effectiveness and long-term impact of Living Labs in dementia care, fostering new collaborations globally.

Indexed as

dementiadigital healthinnovation ecosystemsLiving Labsopen innovation

Identifiers

PMID39050540
PMCPMC11266068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.